MedTrace Logo

Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma

NCT03185325 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2021-01-13

No results posted yet for this study

Summary

Lymphomas are hematological malignancies, which are divided into non-Hodgkin lymphoma and Hodgkin lymphoma. Non hodgkin lymphoma is a lymphoma-derived malignancy that makes up about 90% of all malignant lymphoma. According to its origin, non hodgkin lymphoma is classified into B-cell non hodgkin lymphoma and T-cell non hodgkin lymphoma. The most common types are follicular lymphoma, and diffuse large B-cell lymphoma. Lymphomas are types of cancer that develops from lymphocytes, a type of white blood cell. Diagnosis is by examination of a bone marrow or lymph node biopsy. Non hodgkin lymphoma mortality has increased in recent years and has become the seventh most frequently occurring cancer.

Conditions

  • Non Hodgkin Lymphoma

Interventions

OTHER

bone marrow puncture and venous blood samples

bone marrow and peripheral blood samples are collected in non hodgkin lymphoma patients

OTHER

venous blood samples

venous blood samples are collected in healthy voulnteers

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Merna W Narouz · Assiut University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-10
Primary Completion
2019-04-24
Completion
2019-12-24

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03185325 on ClinicalTrials.gov